Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Schellenberger

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Mabs|July 22, 2022
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activityHarshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, et al.
Science (New York, N.Y.)|October 7, 2016
A selective insecticidal protein from Pseudomonas for controlling corn rootwormsUte Schellenberger, Jarred Oral, Barbara A Rosen, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Plant Biotechnology Journal|August 11, 2017
A selective insecticidal protein from Pseudomonas mosselii for corn rootworm controlJun-Zhi Wei, Jessica O'Rear, Ute Schellenberger, et al.
Scientific Reports|May 20, 2021
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsKatherine E Harris, Kyle J Lorentsen, Harbani K Malik-Chaudhry, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Oncoimmunology|August 26, 2022
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancerBrian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Mabs|July 22, 2022
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activityHarshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, et al.
Science (New York, N.Y.)|October 7, 2016
A selective insecticidal protein from Pseudomonas for controlling corn rootwormsUte Schellenberger, Jarred Oral, Barbara A Rosen, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Plant Biotechnology Journal|August 11, 2017
A selective insecticidal protein from Pseudomonas mosselii for corn rootworm controlJun-Zhi Wei, Jessica O'Rear, Ute Schellenberger, et al.
Scientific Reports|May 20, 2021
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsKatherine E Harris, Kyle J Lorentsen, Harbani K Malik-Chaudhry, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Oncoimmunology|August 26, 2022
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancerBrian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, et al.
Pageof 2